Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VEPPANU safely and effectively. See full prescribing information for VEPPANU. VEPPANU (vepdegestrant) tablets, for oral use Initial U.S. Approval: 2026
Medication labelWhy this: Advisory · dailymed-prescription
VEPPANU is indicated for the treatment of adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, estrogen receptor-1 (ESR1)-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy.
- generic_name
- vepdegestrant
- product_names
- vepdegestrant
- ndc
- 84043-100, 84043-200, 84043-100-30, 84043-200-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en